Published January 18, 2026 · Parkinson's Lawsuit Help
The Philadelphia Court of Common Pleas operates one of the most influential mass tort dockets in the United States. Its paraquat program — currently ~1,799 active cases — has become a focal point of national settlement strategy.
The Complex Litigation Center
The Philadelphia Complex Litigation Center handles mass tort cases under specialized case management orders. The CLC has previously administered Risperdal, Xarelto, talc, and pelvic mesh dockets. Paraquat is the latest large addition.
Judge Joshua Roberts
Judge Joshua Roberts presides over the paraquat mass tort program. The court runs active case management with regular status conferences and trial-ready postures, which gives the docket pace and predictability.
~1,799 active cases
As of early 2026, the Philadelphia program hosts approximately 1,799 active paraquat cases. New filings continue, and the docket continues to grow as Pennsylvania jurisdictional eligibility becomes more widely understood.
Jury composition
Philadelphia juries have a documented history of higher plaintiff verdicts in mass tort cases. The January 2026 Philadelphia paraquat bellwether settled on the courthouse steps minutes before jury selection — a strong indicator of how Syngenta and Chevron view Philadelphia jury risk.
Pace
The Philadelphia program moves faster than typical federal MDL bellwether tracks. Cases reach trial readiness in 12–24 months from filing in many instances.
Eligibility
Plaintiffs from many states are eligible for Philadelphia under Pennsylvania's consent-by-registration jurisdiction, which survived Supreme Court review in October 2025. Your attorney will analyze eligibility for your specific case.
Get a free case review
If you or a family member were exposed to paraquat and have been diagnosed with Parkinson's disease, request a free case review. It takes 15 to 30 minutes by phone, costs nothing, and locks in your place while settlement options remain open. Check eligibility or call (717) 724-7503.